AMGN vs GAP · P/E 24, rev $36.75B vs P/E 9.9, rev $15.09B
Amgen Inc (AMGN) versus The Gap, Inc. (GAP) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Not investment advice. Open the AMGN and GAP stock pages for the full models.
Not investment advice.